Cargando…
Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis
Previous studies have suggested that β-adrenergic signaling may regulate the growth of various cancers. The aim of our study is to investigate the association between the incidental use of beta-blockers for various conditions on the overall survival of patients with pancreatic ductal adenocarcinoma...
Autores principales: | Yang, Anthony, Zylberberg, Haley M., Rustgi, Sheila D., Amin, Sunil P., Bar-Mashiah, Ariel, Boffetta, Paolo, Lucas, Aimee L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807087/ https://www.ncbi.nlm.nih.gov/pubmed/33441781 http://dx.doi.org/10.1038/s41598-020-79999-0 |
Ejemplares similares
-
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis
por: Zylberberg, Haley M., et al.
Publicado: (2021) -
Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016
por: Rustgi, Sheila D., et al.
Publicado: (2022) -
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
por: Fulop, Daniel J., et al.
Publicado: (2023) -
Elevated hemoglobin A1c is associated with the presence of pancreatic cysts in a high-risk pancreatic surveillance program
por: Bar-Mashiah, Ariel, et al.
Publicado: (2020) -
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
por: Le Bozec, Antoine, et al.
Publicado: (2023)